FDA Approves Blood Test to Diagnose Diabetes
barbara.lempert
WASHINGTON, May 23, 2013 (AP) — The Food and Drug Administration said Thursday it approved a new blood test from Roche to help doctors diagnose diabetes.
The Cobas ...
Type 2 Diabetes in Youth Progresses Faster, More Aggressive
barbara.lempert
Type 2 Diabetes in Youth Progresses Faster, More Aggressively Than in Adults, Even Under Optimal Treatment Conditions
TODAY Study Finds Quickly Progressing Co-Morbidities, ...
FDA gives Novartis’ Ilaris big boost with nod for rare juvenile diabetes
Eric Palmer
Novartis has grabbed one of two new indications it was shooting for with its rare disease drug Ilaris, one step toward turning the drug into a blockbuster.
FiercePharma ...
Merck buddies up to Scripps spinout Abide in $430M diabetes partnership
John Carroll
Yesterday Merck's top executives spent a considerable amount of time trying to reassure analysts that the Big Pharma company is actively engaged in the hunt for new ...
Giants team on diabetes as Merck partners with Pfizer on SGLT2 combo
John Carroll
Jockeying for a leading position in the high-stakes race to develop a new generation of blockbuster diabetes drugs, Merck ($ MRK) is hitching a ride with Pfizer’s ...
Johnson & Johnson, Evotec bask in Harvard’s breaking diabetes discovery
Ryan McBride
The German biotech Evotec and Johnson & Johnson ($ JNJ) have the inside track on drug development based on a Harvard lab's discovery of a hormone that spurs replication ...
Sanofi embarks on doc-training in Morocco to boost diabetes, epilepsy care
Tracy Staton
In established markets, Big Pharma targets doctors to boost sales. In emerging markets, drugmakers train them. Directly. Several of the globe's biggest pharma companies ...
Eli Lilly scores upbeat PhIII data for GLP1 drug in busy diabetes market
Ryan McBride
Eli Lilly ($ LLY) has added to a body of positive Phase III data for its once-weekly GLP-1 candidate dulaglutide, with two more late-stage studies that have met their ...